322 related articles for article (PubMed ID: 23853598)
21. Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity.
Lv M; Wang J; Wang X; Zuo T; Zhu Y; Kong W; Yu X
PLoS One; 2011; 6(6):e20890. PubMed ID: 21674066
[TBL] [Abstract][Full Text] [Related]
22. The presence of a vpu gene and the lack of Nef-mediated downmodulation of T cell receptor-CD3 are not always linked in primate lentiviruses.
Schmökel J; Sauter D; Schindler M; Leendertz FH; Bailes E; Dazza MC; Saragosti S; Bibollet-Ruche F; Peeters M; Hahn BH; Kirchhoff F
J Virol; 2011 Jan; 85(2):742-52. PubMed ID: 21068258
[TBL] [Abstract][Full Text] [Related]
23. SIV Nef proteins recruit the AP-2 complex to antagonize Tetherin and facilitate virion release.
Zhang F; Landford WN; Ng M; McNatt MW; Bieniasz PD; Hatziioannou T
PLoS Pathog; 2011 May; 7(5):e1002039. PubMed ID: 21625568
[TBL] [Abstract][Full Text] [Related]
24. Serine Phosphorylation of HIV-1 Vpu and Its Binding to Tetherin Regulates Interaction with Clathrin Adaptors.
Kueck T; Foster TL; Weinelt J; Sumner JC; Pickering S; Neil SJ
PLoS Pathog; 2015 Aug; 11(8):e1005141. PubMed ID: 26317613
[TBL] [Abstract][Full Text] [Related]
25. Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin.
Kluge SF; Mack K; Iyer SS; Pujol FM; Heigele A; Learn GH; Usmani SM; Sauter D; Joas S; Hotter D; Bibollet-Ruche F; Plenderleith LJ; Peeters M; Geyer M; Sharp PM; Fackler OT; Hahn BH; Kirchhoff F
Cell Host Microbe; 2014 Nov; 16(5):639-50. PubMed ID: 25525794
[TBL] [Abstract][Full Text] [Related]
26. Tetherin/BST-2: Restriction Factor or Immunomodulator?
Li SX; Barrett BS; Guo K; Santiago ML
Curr HIV Res; 2016; 14(3):235-46. PubMed ID: 26957198
[TBL] [Abstract][Full Text] [Related]
27. Nef Is Dispensable for Resistance of Simian Immunodeficiency Virus-Infected Macrophages to CD8+ T Cell Killing.
Rainho JN; Martins MA; Cunyat F; Watkins IT; Watkins DI; Stevenson M
J Virol; 2015 Oct; 89(20):10625-36. PubMed ID: 26269172
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.
Pujol FM; Laketa V; Schmidt F; Mukenhirn M; Müller B; Boulant S; Grimm D; Keppler OT; Fackler OT
J Virol; 2016 Aug; 90(15):6709-6723. PubMed ID: 27170757
[TBL] [Abstract][Full Text] [Related]
29. Nef proteins from simian immunodeficiency viruses are tetherin antagonists.
Zhang F; Wilson SJ; Landford WC; Virgen B; Gregory D; Johnson MC; Munch J; Kirchhoff F; Bieniasz PD; Hatziioannou T
Cell Host Microbe; 2009 Jul; 6(1):54-67. PubMed ID: 19501037
[TBL] [Abstract][Full Text] [Related]
30. Purification of eukaryotic tetherin/Vpu proteins and detection of their interaction by ELISA.
Lv M; Zhu Y; Wang J; Zhang H; Wang X; Zuo T; Liu D; Zhang J; Wu J; Kong W; Yu X
Protein Expr Purif; 2013 Oct; 91(2):112-8. PubMed ID: 23916489
[TBL] [Abstract][Full Text] [Related]
31. Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance.
Kmiec D; Iyer SS; Stürzel CM; Sauter D; Hahn BH; Kirchhoff F
mBio; 2016 Aug; 7(4):. PubMed ID: 27531907
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of inactive tetherin delGPI mutant inhibits HIV-1 Vpu-mediated antagonism of endogenous tetherin.
Lv M; Wang J; Zhu Y; Wang X; Zuo T; Liu D; Zhang J; Wu J; Zhang H; Kong W; Yu X
FEBS Lett; 2013 Jan; 587(1):37-43. PubMed ID: 23201263
[TBL] [Abstract][Full Text] [Related]
33. Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein.
Le Tortorec A; Neil SJ
J Virol; 2009 Nov; 83(22):11966-78. PubMed ID: 19740980
[TBL] [Abstract][Full Text] [Related]
34. Antiviral activity of the interferon-induced cellular protein BST-2/tetherin.
Tokarev A; Skasko M; Fitzpatrick K; Guatelli J
AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1197-210. PubMed ID: 19929170
[TBL] [Abstract][Full Text] [Related]
35. Maintenance of AP-2-Dependent Functional Activities of Nef Restricts Pathways of Immune Escape from CD8 T Lymphocyte Responses.
Schouest B; Weiler AM; Janaka SK; Myers TA; Das A; Wilder SC; Furlott J; Baddoo M; Flemington EK; Rakasz EG; Evans DT; Friedrich TC; Maness NJ
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237831
[TBL] [Abstract][Full Text] [Related]
36. In COS cells Vpu can both stabilize tetherin expression and counteract its antiviral activity.
Waheed AA; Kuruppu ND; Felton KL; D'Souza D; Freed EO
PLoS One; 2014; 9(10):e111628. PubMed ID: 25360760
[TBL] [Abstract][Full Text] [Related]
37. Vpu downmodulates two distinct targets, tetherin and gibbon ape leukemia virus envelope, through shared features in the Vpu cytoplasmic tail.
Lucas TM; Janaka SK; Stephens EB; Johnson MC
PLoS One; 2012; 7(12):e51741. PubMed ID: 23284757
[TBL] [Abstract][Full Text] [Related]
38. Determinants in HIV-2 Env and tetherin required for functional interaction.
Exline CM; Yang SJ; Haworth KG; Rengarajan S; Lopez LA; Droniou ME; Seclen E; Cannon PM
Retrovirology; 2015 Aug; 12():67. PubMed ID: 26248668
[TBL] [Abstract][Full Text] [Related]
39. β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release.
Tervo HM; Homann S; Ambiel I; Fritz JV; Fackler OT; Keppler OT
Retrovirology; 2011 Feb; 8():9. PubMed ID: 21310048
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment.
Hauser H; Lopez LA; Yang SJ; Oldenburg JE; Exline CM; Guatelli JC; Cannon PM
Retrovirology; 2010 Jun; 7():51. PubMed ID: 20529266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
